Concepedia
3
Publications
480
Citations
H-Index
1994
Active since
Affiliations
University of San Diego(Current)
University of California San Diego
Mark R. Green is an author at University of San Diego specializing in oncology, radiation oncology, and medicine.
Top concepts
MedicineOncologyRadiation OncologyUrologyPharmacologyCancer TherapyCancer Research
Publications per year
1994–2014
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 440 citations
Oncology, Phase Ii Trial, Pancreatic Cancer +5
A Feasibility Study of Extended Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase II Trial of Cancer and Leukemia Group B
Gerald H. Clamon, James Herndon, Walter L. Eaton et al. · Cancer Investigation · 1994 · 27 citations
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere
Heloisa P. Soares, Soley Bayraktar, Marcelo Blaya et al. · Cancer Chemotherapy and Pharmacology · 2014 · 13 citations
Urology, Pancreatic Cancer, Gastrointestinal Oncology +5
Rows per page
1–3 of 3